TALPHERA, INC. (TLPH) · INSIDERData sourcesSEC Form 44m ago
House PTR4m ago
SEC 13F4m ago
Robinhood Chain3m ago
Public companyTALPHERA, INC.
TLPHCIK 0001427925
Price$1.05
1 year-17.3%
Disclosed transactions11
Buys / sells2 / 0
Max Insider Score51
Connections with evidence6
TLPH · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 21 | BMBozilenko MarinaDirector | TLPHTALPHERA, INC. Grant or award | A | — 5,100 sh | Jun 22, 2026 | Jun 24, 2026 |
| 9 | BMBozilenko MarinaDirector | TLPHTALPHERA, INC. Grant or award | A | — 30.7K sh | Jun 22, 2026 | Jun 24, 2026 traded Jun 22, 2026 | +2d | SEC Form 4 | |
| 21 | | TLPHTALPHERA, INC. Grant or award | A | — 5,100 sh | Jun 22, 2026 | Jun 24, 2026 traded Jun 22, 2026 | +2d | SEC Form 4 | |
| 21 | | TLPHTALPHERA, INC. Grant or award | A | — 5,100 sh | Jun 22, 2026 | Jun 24, 2026 traded Jun 22, 2026 | +2d | SEC Form 4 | |
| 9 | | TLPHTALPHERA, INC. Grant or award | A | — 30.7K sh | Jun 22, 2026 | Jun 24, 2026 traded Jun 22, 2026 | +2d | SEC Form 4 | |
| 9 | | TLPHTALPHERA, INC. Grant or award | A | — 30.7K sh | Jun 22, 2026 | Jun 24, 2026 traded Jun 22, 2026 | +2d | SEC Form 4 | |
| 9 | ASAslam ShakilChief Medical Officer | TLPHTALPHERA, INC. Tax withholding | F | $3,723 4,518 sh | May 20, 2026 | May 21, 2026 traded May 20, 2026 | +1d | SEC Form 4 | |
| 5 | ASAslam ShakilChief Medical Officer | TLPHTALPHERA, INC. Tax withholding | F | $1,530 2,118 sh | Apr 2, 2026 | Apr 3, 2026 traded Apr 2, 2026 | +1d | SEC Form 4 | |
| 50 | AJAngotti Vincent J.Director, CHIEF EXECUTIVE OFFICER | TLPHTALPHERA, INC. Open-market purchase | BUY | $125K 213.3K sh | Mar 13, 2026 | Mar 25, 2026 traded Mar 13, 2026 | +12d | SEC Form 4 | |
| 19 | ASAslam ShakilChief Medical Officer | TLPHTALPHERA, INC. Grant or award | A | — 205.0K sh | Feb 12, 2026 | Feb 20, 2026 traded Feb 12, 2026 | +8d | SEC Form 4 | |
| 51 | ASAslam ShakilChief Medical Officer | TLPHTALPHERA, INC. Open-market purchase | BUY | $28K 35.0K sh | Feb 12, 2026 | Feb 20, 2026 traded Feb 12, 2026 | +8d | SEC Form 4 | |
Director, CHIEF EXECUTIVE OFFICER · Mar 25, 2026